AR
CVS icon

Advisory Research’s CVS Health CVS Stock Holding History

Advisory Research’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-328,177
Closed -$23.8M – 385
2017
Q4 		$23.8M Sell
328,177
-105,272
-24% -$7.65M 0.39% 71
2017
Q3 		$35.2M Buy
433,449
+184,076
+74% +$14.6M 0.56% 55
2017
Q2 		$20.1M Buy
249,373
+205,816
+473% +$16.3M 0.32% 83
2017
Q1 		$3.42M Sell
43,557
-17,160
-28% -$1.37M 0.05% 197
2016
Q4 		$4.79M Sell
60,717
-1,350
-2% -$109K 0.07% 130
2016
Q3 		$5.52M Buy
62,067
+8,124
+15% +$767K 0.09% 114
2016
Q2 		$5.17M Sell
53,943
-17,188
-24% -$1.71M 0.09% 115
2016
Q1 		$7.38M Sell
71,131
-115,270
-62% -$11.2M 0.14% 108
2015
Q4 		$18.2M Sell
186,401
-5,601
-3% -$549K 0.28% 98
2015
Q3 		$18.5M Sell
192,002
-3,401
-2% -$358K 0.26% 102
2015
Q2 		$20.5M Buy
195,403
+33,061
+20% +$3.38M 0.23% 110
2015
Q1 		$16.8M Buy
+162,342
New +$16.4M 0.18% 116
2014
Q2 		– Sell
-942
Closed -$71K – 409
2014
Q1 		$71K Buy
+942
New +$66.5K ﹤0.01% 450

Other funds holding CVS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Parnassus Investments
Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Advisory Research's CVS Position: Q1 2018 in Review

Advisory Research sold out of CVS Health (CVS) in Q1 2018, closing a stake of 328,177 shares — an estimated $23.8M sold.

Advisory Research first reported a position in CVS in Q1 2014 and held it in 13 quarters. The position peaked at $35.2M in Q3 2017. 1,549 funds tracked by Wall St. Rank hold CVS as of Q1 2018.

  • Advisory Research reported no remaining CVS Health position as of Q1 2018 after selling out during the quarter.
  • Advisory Research sold 328,177 CVS Health shares in Q1 2018, an estimated $23.8M.
  • Advisory Research first reported a position in CVS Health in Q1 2014 and held it in 13 quarters.
  • Advisory Research's CVS Health position peaked at $35.2M in Q3 2017.
  • 1,549 funds tracked by Wall St. Rank held CVS Health as of Q1 2018.

Based on Advisory Research's 13F filing for Q1 2018, filed 15 May 2018.